News

Tetraneuron will receive 1M€ from the IVF and FEDER to advance its therapy against Alzheimer’s Disease

  With this new line of funding, Tetraneuron will advance both in the preclinical development of his gene therapy for Alzheimer’s disease and opening a new line of research around glaucoma. E2F4-based gene therapy can mitigate the main molecular, cognitive, and behavioral alterations related to Alzheimer’s disease through a multifactorial…